Redx Pharma appoints leading oncology drug developer, Dr Jane Robertson, as Chief Medical Officer
ALDERLEY PARK: Redx Pharma plc has appointed Dr Jane Robertson as Chief Medical Officer, a news release noted. Jane is a well respected UK haemato-oncologist with over 17 years’ experience of clinical development in oncology and has a breadth of experience investigating multiple tumours and agents including VEGF inhibitors, anti-hormonals, PARP inhibitors, nucleotide analogs and…